Sort
82,697 grants matching “vaccine development”
Validation of the Remote Cognitive Aging and Alzheimerâs Disease REsearch (R-CARE) Toolbox for Diverse Populations
$2,026,753Richard B. Lipton · Albert Einstein College Of Medicine · R01 · FY2025 · AG
Induction of neutralizing antibodies targeting CD4 binding region of HIV-1 Env
$2,026,557Shan Lu · Univ Of Massachusetts Med Sch Worcester · P01 · FY2013 · AI
Plasma Cells in Health and Disease
$2,026,518Ignacio E. Sanz · Emory University · P01 · FY2019 · AI
Influenza vaccination using a microneedle patch
$2,026,290Mark R Prausnitz · Georgia Institute Of Technology · U01 · FY2012 · EB
Re-engineering gp120 to include glycan-dependent epitopes
$2,026,178Phillip Berman · University Of California Santa Cruz · R01 · FY2014 · AI
Plasma Cells in Health and Disease
$2,025,932Ignacio E. Sanz · Emory University · P01 · FY2020 · AI
Pacific Center for Emerging Infectious Diseases Research
$2,025,561Richard Yanagihara · University Of Hawaii At Manoa · P20 · FY2014 · GM
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
$2,024,997Luc Teyton · Scripps Research Institute, The · P01 · FY2023 · AI
Highly multiplexed platforms for diagnosis of infection and immunity
$2,024,611W. Ian Lipkin · Columbia University Health Sciences · U19 · FY2018 · AI
SPORE in Gastrointestinal Cancer
$2,024,526Alison P Klein · Johns Hopkins University · P50 · FY2016 · CA
Prevention of AIDS
$2,024,238Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$2,023,601Hildegund C. J. Ertl · Wistar Institute · U19 · FY2011 · AI
An Advanced Vaccine Candidate To Prevent Zika Virus Infection
$2,022,865Mark K Slifka · Oregon Health & Science University · R01 · FY2019 · AI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination
$2,022,567Nancy Logan Haigwood · Oregon Health & Science University · P01 · FY2009 · AI
HIV VACCINE TRIAL CLINICAL UNIT
$2,022,330Harvard University (Medical School) · U01 · FY2002 · AI
Immunology Core
$2,022,247Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIC · FY2016 · AI
UTHSC RBL Administrative Supplement For Antiviral Discovery & Development
$2,021,906Colleen B Jonsson · University Of Tennessee Health Sci Ctr · G20 · FY2022 · AI
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
$2,021,622Mark Fredric Cotton · Stellenbosch University · U01 · FY2011 · AI
Host-Tumor Cell Interactions in Myeloma:
$2,021,516Dana-Farber Cancer Institute · P01 · FY2005 · CA
Clinical Epidemiology and Pathogenesis of Asymptomatic HSV
$2,021,461Anna Wald · Fred Hutchinson Cancer Research Center · P01 · FY2012 · AI
Characterization of novel genes encoded ty RNA and DNA viruses
$2,021,134Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2017 · AI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination
$2,021,024Nancy Logan Haigwood · Oregon Health & Science University · P01 · FY2010 · AI
Integrative analysis and modeling of human immune responses and pathologies
$2,020,923John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Host-Tumor Cell Interactions in Myeloma:
$2,020,671Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2006 · CA
Zika virus pathophysiology during pregnancy
$2,020,452David H Oconnor · University Of Wisconsin-Madison · P01 · FY2022 · AI